Biogen (BIIB) YTD return

Updated November 02, 2026 · Data: Yahoo Finance

+41.49%
YTD return in 2026 (from Dec 31, 2025 close)
Dec 31, 2025 close$175.99
Current price$249.01
$1,000 on Dec 31 →$1,414.90
YTD rank#66 of 500
SectorHealth Care
Official websitebiogen.com

Price chart

BIIB vs its sector

Health Care sector average+29.73%
BIIB YTD+41.49%
Difference+11.76 pts
Stocks in sector60

Outperforming its sector. BIIB is 11.76 points ahead of the Health Care sector average, which covers 60 ranked S&P 500 stocks.

Biogen (BIIB) is up +41.49% year-to-date in 2026, ranking #66 of 500 ranked S&P 500 stocks. It closed 2025 at $175.99 and trades at $249.01 as of November 02, 2026. $1,000 invested on December 31, 2025 would be worth $1,414.90 today. That puts it 11.76 points ahead of the Health Care sector average of +29.73%.

Recent performance

Biogen (BIIB) has gained 13.25% over the past month, outpacing the S&P 500 by 15.60%, and gained 19.46% over the past three months (ahead of the index by 21.98%). It is trading 1.90% below its 52-week high of $253.84, set on 2026-10-22.

Latest BIIB news

Headlines via Yahoo Finance, updated daily.

Where to invest in BIIB

Popular stock brokerages:

We may earn a commission if you sign up through these links, at no extra cost to you.

BIIB YTD return FAQ

What is Biogen (BIIB)'s YTD return in 2026?

Biogen (BIIB) is up +41.49% year-to-date in 2026, as of November 02, 2026.

What was Biogen (BIIB)'s price at the start of 2026?

Biogen (BIIB) closed at $175.99 on December 31, 2025 and trades at $249.01 as of November 02, 2026.

Where does Biogen (BIIB) rank by YTD return in 2026?

Biogen (BIIB) ranks #66 of 500 S&P 500 stocks by YTD return in 2026, as of November 02, 2026.

← Full S&P 500 YTD leaderboard

For informational purposes only, not financial advice.

© 2026 MZX MEDIA LLC. All rights reserved.